Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective lifted by Cantor Fitzgerald from $750.00 to $795.00 in a research report sent to investors on Friday morning,Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the biopharmaceutical company’s stock. Several other equities analysts also recently weighed in on REGN. Citigroup downgraded Regeneron Pharmaceuticals […]

Kiniksa Pharmaceuticals International (NASDAQ:KNSA – Get Free Report) had its target price lifted by equities researchers at The Goldman Sachs Group from $60.00 to $75.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. The Goldman Sachs Group’s price target indicates a potential upside […]

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price objective upped by equities research analysts at Guggenheim from $995.00 to $1,000.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Guggenheim’s price objective would indicate a potential upside of 47.84% from the company’s current […]

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) had its price target cut by equities research analysts at HC Wainwright from $54.00 to $52.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price objective would suggest a potential […]